Home > Event > Clinical Nuclear Medicine update in bone and cardiovascular diseases and prostate cancer
<< Back to the Events

Clinical Nuclear Medicine update in bone and cardiovascular diseases and prostate cancer

International Event

Starting time 01.06.2018 at 08:00
Ending time 02.06.2018 at 14:30

 

FANC points: 9 hours for nuclear medicine physicians (NL: nuclearisten/ FR: médecins nucléaristes).

 

Please find the registration form by using the following link 

 

 

 

Friday 1st of June 2018

 

ORTHOPEDIC DISEASES

 

Foot and ankle

8h00-8h20

Clinical questions   from the orthopedic

Stefan Clockaerts, AZ Groeninge, Kortrijk, Belgium

8h20-8h40

Role of CT and MRI   Imaging

Giuseppe Argento, S. Andrea Hospital, Rome, Italy

8h40-9h00

Bone SPECT/CT imaging

Christophe Van de Wiele, UGent, Belgium

 

Knee

9h00-9h20

Clinical questions   from the orthopedic

Nele Arnout, UGent, Ghent, Belgium

9h20-9h40

Role of CT and MRI   Imaging

Koenraad   Verstraete, UGent, Ghent, Belgium

9h40-10h00

Bone SPECT/CT imaging

Dominic Mathis, Basel, Switzerland

 

10h00-10h30   Coffee break

 

Hip

10h30-10h50

Clinical questions   from the orthopedic surgeon

Paul Jutte, UMCG,   Groningen, The Netherlands

10h50-11h10

Role of CT and MRI   Imaging.

Thomas Kwee, UMCG,   Groningen, The Netherlands

11h10-11h30

Bone SPECT/CT imaging.  

Alex Maes, KULeuven, Belgium

 

Spine

11h30-11h50

Clinical questions   from the neuroradiologist

Luigi Manfrè, Istituto   Oncologico del Mediterraneo, Catania, Italy

11h50-12h10

Role of CT and MRI   Imaging

Frederic   Van Rietvelde, AZGroeninge, Belgium

12h10-12h30

Bone SPECT/CT imaging

Olivier Gheysens, KULeuven, Belgium

 

Imaging infection in orthopedics

12h30-12h50

Bone imaging in sport medicine

Rudi Dierckx, UMCG, Groningen, The Netherlands   

12h50-13h10

Infection imaging of osteomyelitis

Alberto Signore, “Sapienza”   University of Rome, Italy

 

13h10-15h00   Lunch break

 


 

AGGIORNAMENTO IN PATOLOGIA PROSTATICA (session in Italian)

 

Update del ruolo della Medicina Nucleare in patologia prostatica

15h00-15h20

Ruolo della scintigrafia   miocardica nel pre-operatorio

Carlo Vigneri, O.   Vittorio Emanuele, Catania

15h20-15h40

Ruolo della scintigrafia   ossea nelle metastasi ossee

Giovanni D’Agostino, O.   Gravina e Santo Pietro, Caltagirone (CT)

15h40-16h00

La PET con NaF per la   diagnosi delle metastasi ossee

Serena Castorina, O.   Umberto I, Enna

 

16h00-16h30   Coffee break

 

16h30-16h50

PET con FDG: che ruolo   nel carcinoma della prostata?

Simona Russo, O.   Garibaldi, Catania

16h50-17h10

PET con colina e PSMA nel   cancro della prostata

Dr.ssa Murè, O. Cannizzaro,   Catania.

17h10-17h30

Terapia delle metastasi   ossee con 223RaCl2

Demetrio Aricò,   Humanitas, Catania

 

17h30-18h30   Tavola rotonda e discussione con gli esperti

 

                        Moderatori: Luigi Castorina (MN Viagrande CT), Massimo Ippolito (MN Catania)

 

Discussants: Mario Falsaperla (Urologo Catania) Concetta Fornito (MN Catania),   Rosario Leonardi (Urologo Catania), Filippo Marranzano (MN Catania), Concetto Scuderi (MN Caltagirone CT), Sergio Sportelli (MN Catania)

 

 

20h00-23h00   Social dinner                                                                                                  


 

Saturday 2nd of June 2018

 

CARDIAC IMAGING

 

9.00h-9h20

Imaging   protocols in obese patients

Valeria Gaudieri, Napoli,   Italy

9h20-9h40

New SPECT and PET   tracers for cardiac imaging

Véronique   Roelants, UCL, Leuven, Belgium

9h40-10h00

New technologies in nuclear cardiac imaging

Pieter de   Bondt, OLV Hospital Aalst, Belgium

10h00-10h20

Resolution recovery   imaging protocols, impact on reporting

Christophe van de Wiele,   UGent, Ghent, Belgium

10h20-10h40

Sponsored lecture by   GE Healthcare

 

10h40-11h10   Coffee break

 

DIAGNOSIS AND THERAPY OF PROSTATE CANCER

 

PET/CT imaging

11h10-11h30

The role of [18F]-NaF   PET/CT in prostate cancer.

Rachele   Bonfiglioli, Bologna, Italy

11h30-11h50

The role of [18F]-Choline   PET/CT in prostate cancer.

Rachele   Bonfiglioli, Bologna, Italy

11h50-12h10

The role of 68Ga-PSMA   PET/CT imaging in prostate cancer

Felix   Mottaghy, Aachen, Germany

 

Therapy of prostate cancer

12h10-12h30

177Lu-PSMA therapy.

Giovanni Paganelli,   Ferrara, Italy

12h30-12h50 

Astatine and 177Lu-PSMA   therapy: the SA experience.

Mike Sathekge, Pretoria,   South Africa

12h50-13h10

223RaCl2 for bone metastases.

Giuseppe De Vincentis,   “Sapienza” University of Rome, Italy

 

13h10-14h30   Lunch break

Final Program_v1.pdf
Download the document